Origin of mineralizing fluids of the sediment-hosted Navachab gold mine, Namibia: Constraints from stable (O, H, C, S) isotopes

The Navachab gold mine in the Damara belt of central Namibia is characterized by a polymetallic Au-Bi-As-Cu-Ag ore assemblage, including pyrrhotite, chalcopyrite, sphalerite, arsenopyrite, bismuth, gold, bismuthinite, and bismuth tellurides. Gold is hosted by quartz sulfide veins and semimassive sulfide lenses that are developed in a near-vertical sequence of shelf-type metasedimentary rocks, including marble, calcsilicate rock, and biotite schist. The sequence has been intruded by abundant syntectonic lamprophyre, aplite, and pegmatite dikes, documenting widespread igneous activity coeval with mineralization. The majority of quartz from the veins has delta(18)O values of 14 to 15 per mil (V-SMOW). The total variations in delta(18)O values of the biotite schist and calcsilicate rock are relatively small (12-14 parts per thousand), whereas the marble records steep gradients in delta(18)O values (17-21 parts per thousand), the lowest values being recorded at the vein margins. Despite this, there is no correlation between delta(18)O and delta(13)C values and the carbonate content of the rocks, indicating that fluid-rock interaction alone cannot explain the isotopic gradients. In addition, the marble records increased delta(13)C values at the contact to the veins, possibly related to a change in the physicochemical conditions during fluid-rock interaction. Gold is interpreted to have precipitated in equilibrium with metamorphic find (delta(18)O 12-14 parts per thousand; delta D = -40 to -60 parts per thousand) at peak metamorphic conditions of ca. 550 degrees C and 2 kbars, consistent with isotopic fractionations between coexisting calcite, garnet, and clinopyroxene in the alteration halos. The most likely source of the mineralizing fluid was a midcrustal fluid in equilibrium with the Damaran metapelites that underwent prograde metamorphism at amphibolite- to granulite-facies grades. Although there is no isotopic evidence for the contribution of magmatic fluids, they may have been important in contributing to the overall hydraulic regime and high apparent geothermal gradients (ca. 80 degrees C/km(-1)) in the mine area.

Genetic Loci Associated with C-reactive Protein Levels and Risk of Coronary Heart Disease.

CONTEXT: Plasma levels of C-reactive protein (CRP) are independently associated with risk of coronary heart disease, but whether CRP is causally associated with coronary heart disease or merely a marker of underlying atherosclerosis is uncertain. OBJECTIVE: To investigate association of genetic loci with CRP levels and risk of coronary heart disease. DESIGN, SETTING, AND PARTICIPANTS: We first carried out a genome-wide association (n = 17,967) and replication study (n = 13,615) to identify genetic loci associated with plasma CRP concentrations. Data collection took place between 1989 and 2008 and genotyping between 2003 and 2008. We carried out a mendelian randomization study of the most closely associated single-nucleotide polymorphism (SNP) in the CRP locus and published data on other CRP variants involving a total of 28,112 cases and 100,823 controls, to investigate the association of CRP variants with coronary heart disease. We compared our finding with that predicted from meta-analysis of observational studies of CRP levels and risk of coronary heart disease. For the other loci associated with CRP levels, we selected the most closely associated SNP for testing against coronary heart disease among 14,365 cases and 32,069 controls. MAIN OUTCOME MEASURE: Risk of coronary heart disease. RESULTS: Polymorphisms in 5 genetic loci were strongly associated with CRP levels (% difference per minor allele): SNP rs6700896 in LEPR (-14.8%; 95% confidence interval [CI], -17.6% to -12.0%; P = 6.2 x 10(-22)), rs4537545 in IL6R (-11.5%; 95% CI, -14.4% to -8.5%; P = 1.3 x 10(-12)), rs7553007 in the CRP locus (-20.7%; 95% CI, -23.4% to -17.9%; P = 1.3 x 10(-38)), rs1183910 in HNF1A (-13.8%; 95% CI, -16.6% to -10.9%; P = 1.9 x 10(-18)), and rs4420638 in APOE-CI-CII (-21.8%; 95% CI, -25.3% to -18.1%; P = 8.1 x 10(-26)). Association of SNP rs7553007 in the CRP locus with coronary heart disease gave an odds ratio (OR) of 0.98 (95% CI, 0.94 to 1.01) per 20% lower CRP level. Our mendelian randomization study of variants in the CRP locus showed no association with coronary heart disease: OR, 1.00; 95% CI, 0.97 to 1.02; per 20% lower CRP level, compared with OR, 0.94; 95% CI, 0.94 to 0.95; predicted from meta-analysis of the observational studies of CRP levels and coronary heart disease (z score, -3.45; P < .001). SNPs rs6700896 in LEPR (OR, 1.06; 95% CI, 1.02 to 1.09; per minor allele), rs4537545 in IL6R (OR, 0.94; 95% CI, 0.91 to 0.97), and rs4420638 in the APOE-CI-CII cluster (OR, 1.16; 95% CI, 1.12 to 1.21) were all associated with risk of coronary heart disease. CONCLUSION: The lack of concordance between the effect on coronary heart disease risk of CRP genotypes and CRP levels argues against a causal association of CRP with coronary heart disease.

Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.

BACKGROUND: Hepatitis C virus (HCV) infection has a growing impact on morbidity and mortality in patients infected with human immunodeficiency virus (HIV). We assessed trends in HCV incidence in the different HIV transmission groups in the Swiss HIV Cohort Study (SHCS). METHODS: HCV infection incidence was assessed from 1998, when routine serial HCV screening was introduced in the SHCS, until 2011. All HCV-seronegative patients with at least 1 follow-up serology were included. Incidence rates (IRs) of HCV infections were compared between men who have sex with men (MSM), injection drug users (IDU), and heterosexuals (HET). RESULTS: HCV incidence was assessed in 3333 MSM, 123 IDU, and 3078 HET with a negative HCV serology at baseline. Over 23 707 person-years (py) for MSM, 733 py for IDU, and 20 752 py for HET, 101 (3%), 41 (33%), and 25 (1%) of patients seroconverted, respectively. The IR of HCV infections in MSM increased from 0.23 (95% credible interval [CrI], .08-.54) per 100 py in 1998 to 4.09 (95% CrI, 2.57-6.18) in 2011. The IR decreased in IDU and remained <1 per 100 py in HET. In MSM, history of inconsistent condom use (adjusted hazard ratio [HR], 2.09; 95% CI, 1.33-3.29) and past syphilis (adjusted HR, 2.11; 95% confidence interval [CI], 1.39-3.20) predicted HCV seroconversion. CONCLUSIONS: In the SHCS, HCV infection incidence decreased in IDU, remained stable in HET, and increased 18-fold in MSM in the last 13 years. These observations underscore the need for improved HCV surveillance and prevention among HIV-infected MSM.

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.

BACKGROUND: The International Breast Cancer Study Group (IBCSG) conducted two complementary randomized trials to assess whether a treatment-free gap during adjuvant chemotherapy influenced outcome. PATIENTS AND METHODS: From 1993 to 1999, IBCSG Trials 13-93 and 14-93 enrolled 2215 premenopausal and postmenopausal women with axillary node-positive, operable breast cancer. All patients received cyclophosphamide (Cytoxan, C) plus either doxorubicin (Adriamycin, A) or epirubicin (E) for four courses followed immediately (No Gap) or after a 16-week delay (Gap) by classical cyclophosphamide, methotrexate, and fluorouracil (CMF) for three courses. The median follow-up was 7.7 years. RESULTS: The Gap and No-Gap groups had similar disease-free survival (DFS) and overall survival (OS). No identified subgroup showed a statistically significant difference, but exploratory subgroup analysis noted a trend towards decreased DFS for Gap compared with No Gap for women with estrogen receptor (ER)-negative tumors not receiving tamoxifen, especially evident during the first 2 years. CONCLUSIONS: A 16-week gap between adjuvant AC/EC and CMF provided no benefit and may have increased early recurrence rates in patients with ER-negative tumors.

Équipe Olympique [football] association, stade Bergeyre 9/11/19, match Olympique contre [F. C. E.] de Levallois : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56847

Équipe [de] Levallois [football] association, [stade Bergeyre] 9/11/19, match Olympique [de Paris] contre [F. C. E.] de Levallois : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56848

The C-Jun N-Terminal Kinase Inhibition in Intracerebral Hemorrhage

Background: In intracerebral hemorrhage (ICH), a subtype of stroke, the bloodentry into the brain triggers toxicity resulting in a strong loss of neurons andinflammation. Water content is also increases leading to growing intracranial pressure,which worsens neurological outcome. C-Jun N-terminal kinases (JNKs) areactivated in response to stress stimuli. Specific inhibition of JNK by a TAT-coupledpeptide (XG-102) mediates neuroprotection in several models of ischemic stroke.Recently, we have noted that the JNK pathway is also activated in a mouse modelof ICH, raising the question of the efficacy of XG-102 in this model.Method: ICH was induced in the mouse by intrastriatal injection of bacterialcollagenase (0,1U). Three hours later, animals received an i.v. injection of XG-102(100μg/kg). The neuroscore was assessed using a scale (from 0 to 9) based on 3behavioral tests performed daily. Then, mice were sacrificed at 6h, 24h, 48h and 5dafter ICH and histological studies performed.Results: XG-102 significantly improves neurological outcome at 24h (mean score:1,8±1.4 vs 3,4±1.8, p<0.01). Analysis of the lesion volume revealed a significantdecrease of the lesion area in the treated group at 48h (29±11 mm3 vs 39±5 mm3,p = 0.04). XG-102 mainly inhibits the edema component of the lesion. Indeed, asignificant decrease of the brain swelling was observed in treated animals at 48h(14±13% vs 26±9%, p=0.04) and 5d (-0,3±4.5% vs 5,1±3.6%, p=0.01).Conclusions: Inhibition of the JNK pathway by XG-102 appears to lead to asignificant decrease of the cerebral edema in the ICH model providing a furtherbeneficial effect of the XG-102 treatment. This result is of interest becausecurrently, clinical treatment for brain edema is limited. Importantly, the beneficialeffects observed with XG-102 in both stroke models open the possibility to rapidlytreat patients before identifying the stroke subtype by imaging.

A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.

Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased total frequency of solid tumors. The distribution and frequency of specific types of brain tumors have never been studied in DS. We evaluated the frequency of primary neural cell embryonal tumors and gliomas in a large international data set. The observed number of children with DS having a medulloblastoma, central nervous system primitive neuroectodermal tumor (CNS-PNET) or glial tumor was compared to the expected number. Data were collected from cancer registries or brain tumor registries in 13 countries of Europe, America, Asia and Oceania. The number of DS children with each category of tumor was treated as a Poisson variable with mean equal to 0.000884 times the total number of registrations in that category. Among 8,043 neural cell embryonal tumors (6,882 medulloblastomas and 1,161 CNS-PNETs), only one patient with medulloblastoma had DS, while 7.11 children in total and 6.08 with medulloblastoma were expected to have DS. (p 0.016 and 0.0066 respectively). Among 13,797 children with glioma, 10 had DS, whereas 12.2 were expected. Children with DS appear to be specifically protected against primary neural cell embryonal tumors of the CNS, whereas gliomas occur at the same frequency as in the general population. A similar protection against neuroblastoma, the principal extracranial neural cell embryonal tumor, has been observed in children with DS. Additional genetic material on the supernumerary chromosome 21 may protect against embryonal neural cell tumor development.

13

L'analyse globale (tab. 1) révèle qu'à quelques rares exceptions, la biodiversité s'est notablement appauvrie entre 1900 et 1990. Durant les vingt dernières années, le recul des effectifs de nombreuses espèces et l'érosion de la surface de certains habitats ont pu être ralentis. Dans de rares cas une évolution positive a même été constatée. Ces développements, encourageants en soi, ne se sont toutefois opérés qu'à partir d'un très faible niveau de biodiversité. Sur le Plateau suisse notamment, son état est très préoccupant.Dans l'ensemble, il n'a pas été possible d'enrayer le déclin de la biodiversité; nous n'avons pas encore touché le fond. Selon nos prévisions pour 2020 une tendance générale à la hausse, voire un véritable inversement de tendance, n'est pas possible dans les conditions actuelles (lois, instruments et mesures, respectivement mise en oeuvre de ces outils). La persistance de cet appauvrissement est notamment imputable à l'intensification de l'exploitation agricole des régions de montagne, à l'extension du milieu urbain et à l'accroissement des activités de tourisme et de loisir. A cela s'ajoutent de nouveaux facteurs de menace, tels que l'expansion des espèces invasives et les répercussions directes et indirectes des changements climatiques qui augmenteront encore la pression sur les espèces et les écosystèmes déjà menacés.

Mineralização do C e do N em amostras armazenadas de solo cultivado com cana-de-açúcar, ao longo de dez anos, com e sem fertilização nitrogenada

As taxas de mineralização do C e do N foram estimadas em amostras de um Podzólico Vermelho-Amarelo latossólico álico textura arenosa, retiradas nas profundidades de 0-20, 20-40 e 40-60 cm, ao longo dos 10 anos de um experimento de campo com cana-de-açúcar, de parcelas com e sem fertilização nitrogenada (60 kg ha-1 de N na forma de uréia). A mineralização do N foi medida por meio da técnica de incubação com percolação periódica e a do C pela quantidade de C-CO2 absorvida em solução de NaOH 1 mol L-1, por titulação potenciométrica. Em geral, apenas na camada superficial, o N total mineralizado acumulado durante as 20 semanas de incubação foi maior, 13% a mais no tratamento fertilizado que no não fertilizado. Entre épocas de amostragem, ao longo dos 10 anos, dentro de cada tratamento, houve diferenças significativas nas três profundidades. No entanto, as épocas de maiores mineralizações não foram as mesmas para todas as profundidades e tratamentos e não mostraram nenhuma tendência mais consistente. O C total mineralizado não diferiu significativamente entre os tratamentos (fertilizado e não fertilizado). As curvas de mineralização de C seguiram uma tendência mais linear que as do N, indicando uma possível estabilização nas taxas de mineralização entre 8 e 20 semanas. Os valores de produção média de C e N mineralizados foram de 611 e 26, 411 e 17 e 427 e 15 mg kg-1 de solo, para as profundidades de 0-20, 20-40 e 40-60 cm, respectivamente. O resultado mais importante foi a manutenção do potencial de mineralização de N do solo ao longo dos 10 anos de cultivo com cana, mesmo nas amostras provenientes das parcelas sem fertilização.

Cultivo consorciado de aveia e ervilhaca: relação C/N da fitomassa e produtividade do milho em sucessão

A aveia e a ervilhaca são as principais culturas de cobertura de solo utilizadas durante o inverno na região sul do Brasil. O cultivo consorciado dessas duas espécies, estratégia ainda pouco utilizada, pode potencialmente resultar numa fitomassa com relação C/N mais equilibrada do que aquela proveniente das culturas solteiras, bem como proporcionar resíduos culturais que atuem, simultaneamente, na proteção do solo contra os agentes erosivos e no suprimento de N ao milho. Com o objetivo de avaliar esta hipótese, realizou-se este trabalho, durante o ano agrícola de 1992/93, em área do Departamento de Solos da Universidade Federal de Santa Maria, num Argissolo Vermelho distrófico arênico (Hapludalf). Os tratamentos constaram de diferentes proporções de densidade de semeadura de ervilhaca comum (E) e aveia preta (A): T1: 100% E (80 kg ha-1de sementes); T2: 90% E (72 kg ha-1) + 10% A (8 kg ha-1); T3: 75% E (60 kg ha-1) + 25% A (20 kg ha-1); T4: 50% E (40 kg ha-1) + 50% A (40 kg ha-1); T5: 25% E (20 kg ha-1) + 75% A (60 kg ha-1) e T6: 100% A (80 kg ha-1). Além desses, foram utilizados dois tratamentos, nos quais o solo permaneceu em pousio durante o inverno: no primeiro tratamento, foram aplicados 75 kg ha-1 de N-uréia no milho (T7) e, no segundo, a cultura foi plantada sem adubação nitrogenada (T8). Em sucessão à ervilhaca como cultura solteira, com relação C/N de 13,5, a produtividade de grãos de milho chegou a 5,44 t ha-1, não diferindo do tratamento em pousio com aplicação de N-uréia. Todavia, a ervilhaca foi rapidamente decomposta e, seis meses após o seu manejo, apenas 19,5% da fitomassa inicial encontrava-se na superfície do solo. Com a inclusão da aveia em consórcio com a ervilhaca ocorreu um aumento gradativo na relação C/N da fitomassa, diminuindo o fornecimento de N ao milho e aumentando a persistência dos resíduos culturais. O consórcio que apresentou melhor equilíbrio entre produção de fitomassa, proteção do solo pelos resíduos culturais e fornecimento de N ao milho foi o que continha 10% de aveia + 90% de ervilhaca (relação C/N = 18,6).